tirzepatide semaglutide head to head A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Semaglutide vs Tirzepatide: Effectiveness, Side

Description

For those with type 2 diabetes, who typically experience less weight loss on GLP-1 therapies, MariTide still achieved an impressive approximately 17% average weight loss and lowered HbA1c by up to 2.2 percentage points over the same period

Even patients with insurance coverage that brings their GLP-1 copay down to $100/month would still pay around $1,440/year for medication plus $199/year for PlushCare membership totaling $1,639 versus $1,752 at Losing Weight RX

As the 2026 New Year weight loss season approaches, individuals researching affordable GLP-1 access options may review MEDVis current offerings to determine whether the platform aligns with their needs and preferences